Future of Healthcare, Medical Devices
LivaNova | February 03, 2023
On February 02, 2023, LivaNova PLC, a medical innovation and technology company, has launched an implantable pulse generator (IPG) SenTiva DUO™, useful for VNS Therapy™ of drug-resistant epilepsy.
With a dual-pinned header, it offers similar therapeutic benefits as SenTiva, the company's earlier product, which stimulates a response to the rapid heart rate, which can be a result of seizures, the low heart rate, and similar situations with day and night programming...
Read More